Impact Biomedical (IBO) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
IMPACT BIOMEDICAL INC.  (NYSE: IBO)

Select the Financial Report: Select the Period:


Description of Impact Biomedical's Business Segments


Impact BioMedical, Inc. operates in a single business segment: Biotechnology. The company focuses on research, development, and commercialization of medical and pharmaceutical solutions addressing unmet medical needs. Impact BioMedical advances drug discovery targeting neurological, oncology, and immunological diseases through technology and strategic partnerships. Additionally, the company develops alternative sugar products for diabetes management and functional fragrance formulations for industrial and medical applications.


Composition of IMPACT BIOMEDICAL INC. Revenues by Segments

 
Biotech Retail Sales    333.33 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Biotech Retail Sales 0.01 333.33 %
Total 0.00 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Biotech Retail Sales - -
Total - -




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -0.70 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.